C. Lamb, S. Sebastian, A. Kent, Jonathan P. Segal, H. Gonzalez, M. Brookes, S. Mehta, S. Subramanian, N. Bhala, L. Hicks, T. Conley, K. Patel, G. Walker, N. Kennedy
{"title":"ATU-3 Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from PREPARE-IBD","authors":"C. Lamb, S. Sebastian, A. Kent, Jonathan P. Segal, H. Gonzalez, M. Brookes, S. Mehta, S. Subramanian, N. Bhala, L. Hicks, T. Conley, K. Patel, G. Walker, N. Kennedy","doi":"10.1136/gutjnl-2021-bsg.41","DOIUrl":null,"url":null,"abstract":"ATU-3 Frigure 1ConclusionsOur data provide reassurance for the continued evidence-based use of corticosteroids, immunomodulators and biologic therapies in IBD during the ongoing COVID-19 pandemic, and is consistent with an as yet unexplained association between mesalazine use and severe COVID-19 outcomes.","PeriodicalId":112484,"journal":{"name":"Abstracts of distinction","volume":"377 2","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Abstracts of distinction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/gutjnl-2021-bsg.41","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
ATU-3 Frigure 1ConclusionsOur data provide reassurance for the continued evidence-based use of corticosteroids, immunomodulators and biologic therapies in IBD during the ongoing COVID-19 pandemic, and is consistent with an as yet unexplained association between mesalazine use and severe COVID-19 outcomes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
